Rua Bioscience announced another milestone in its export strategy with the signing of a two-year distribution agreement with Target Healthcare, a pharmaceutical distributor based in the United Kingdom. This agreement marks a crucial step in Rua Bioscience's commitment to broadening its international presence and ensuring the accessibility of its premium medicinal cannabis products on a global scale. Leveraging the extensive network of Target Healthcare, Rua Bioscience aims to distribute its products across the United Kingdom, capitalising on this rapidly growing medicinal cannabis market.

Target Healthcare is an ideal distribution partner for Rua Bioscience, focusing specifically on the niche segment of the pharmaceutical sector where medicinal cannabis holds a significant position. Rua Bioscience remains focused on its strategy of establishing distribution channels in key export markets and distributing unique Tairawhiti east coast cannabis varieties in these markets.